NeoStrata launches new Glycolic Mousse Cleanser and PHA Daily Moisturiser

| March 18, 2022

The NEW NeoStrata® Resurface Glycolic Mousse Cleanser


This high-strength foaming cleanser with an amphoteric system, is designed to deliver the benefits of Glycolic Acid and Bionic Acid while minimising the potential for irritation. It lightly exfoliates and cleanses clogged pores to prepare the skin for the regimen that follows. Suitable for normal and oily skin types.

Benefits:

  • High strength Alpha Hydroxy Acid (AHA) cleanser
  • Skin renewal and preparation in one simple step
  • Minimises the potential for irritation
  • Soap-free cleanser

Key Ingredients and Actions:

10% Glycolic Acid
Exfoliates skin, refines skin texture, clarifies pores and improves uneven skin tone.

2% Lactobionic Acid
Exfoliator and antioxidant that protects against future damage by targeting the MMP enzyme responsible for degradation of collagen and subsequent wrinkling and skin laxity.

The NEW NeoStrata® Restore PHA Daily Moisturizer

From the founders of Polyhydroxy Acids (PHAs), this lightweight anti-ageing moisturiser for sensitive skin gently exfoliates to improve skin texture and radiance. The PHA formula supports skin’s natural collagen and provides skin texture and firming benefits. Ideal for patients with sensitive or rosacea-prone skin, or those who have recently had cosmetic procedures and want potent anti-ageing solutions without irritation.

Benefits:

  • Light exfoliation for smoother, softer skin
  • Effective visible anti-ageing for sensitive skin
  • Hydration of the skin’s moisture barrier
  • Evens skin tone for enhanced overall clarity

Key Ingredients and Actions:

4% Polyhydroxy Acid
Supports skin’s natural collagen and provides smoother texture and firmer-looking skin.
Antioxidants (Lilac Plant Cell Extract & Vitamin E)
Helps defend against the visible effects of oxidative damage from everyday exposure to drying environmental aggressors.

For a full list of stockists, visit www.neostrata.co.za

Category: Latest News

Comments are closed.